|Bid||88.12 x 800|
|Ask||96.88 x 800|
|Day's Range||87.75 - 91.87|
|52 Week Range||77.30 - 114.99|
|Beta (5Y Monthly)||0.87|
|PE Ratio (TTM)||25.99|
|Earnings Date||Feb 26, 2024 - Mar 01, 2024|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||111.33|
Subscribe to Yahoo Finance Plus to view Fair Value for ADUS
DaVita, Option Care Health, Addus HomeCare and Pennant have been highlighted in this Industry Outlook article.
Despite the macroeconomic challenges, dependence on telehealth and AI dominance are likely to drive the Zacks Medical - Outpatient and Home Healthcare industry. DVA, OPCH, ADUS and PNTG are well-poised to gain.
ADUS vs. USPH: Which Stock Is the Better Value Option?